Business Context and Reporting Period
This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. on July 10, 2018. The filing addresses Item 8.01 (Other Events) regarding the continuation of a registered offering for shares underlying previously issued warrants.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing related to securities registration.
Material Changes
The material event reported is the filing of a prospectus supplement on July 10, 2018, to continue the registration of 1,603,442 shares of common stock (the "Warrant Shares") underlying existing warrants. This action was necessary because the prior registration statement (File No. 333-205168) expired on July 9, 2018, three years after its effective date.
Guidance, Outlook, and Management Commentary
- Contractual Obligation: The filing satisfies a requirement under a Securities Purchase Agreement dated December 23, 2015, which obligates the Company to maintain an effective registration statement for the Warrant Shares for a five-year term expiring on December 23, 2020.
- Exercise Price: The existing warrants allow for the purchase of shares at an exercise price of $3.74.
- No New Issuance: The 2018 Prospectus does not relate to the issuance of additional shares beyond the 1,603,442 shares already underlying the existing warrants, nor are any new warrants being issued.
- Legal Opinion: Snell & Wilmer L.L.P. delivered a legal opinion regarding the validity of the Warrant Shares, filed as an exhibit to this report.
Investor Verification Checklist
- Verify the expiration date of the existing warrants (December 23, 2020).
- Confirm the total number of shares underlying the existing warrants (1,603,442).
- Review the Securities Purchase Agreement dated December 23, 2015, for specific terms regarding the registration obligation.
- Check the legal opinion from Snell & Wilmer L.L.P. (Exhibit 5.1) for any conditions on the validity of the shares.